A L-phenylalanlylglycylglycine- (H-L-PheGlyGly-) terminated polyrotaxane in which many alpha-cyclodextrins (alpha-CDs) are threaded onto poly(ethylene oxide) (PEO) was synthesized to evaluate the effect of alpha-CD threading on the degradation of the terminal H-L-PheGlyGly by a membrane-bound metalloexopeptidase (aminopeptidase M). The threading of alpha-CDs and introducing H-L-PheGlyGly to the terminals were confirmed by gel permeation chromatography and (1)H NMR spectroscopies. In vitro degradation and kinetic studies revealed that the supramolecular structure of the polyrotaxane enhanced the accessibility toward aminopeptidase M despite the higher molecular weight of the polyrotaxane (M(n): approximately 16,000). This finding provides a new design of biodegradable polymers for biomedical applications with controlled degradation profile.
No takes yet. Share an insight, caveat, or question.
Ooya et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: